- Reaction score
- 179
so what else matters? with agonists there is affinity(how much force attraction is there between the ligand and the receptor) and efficiency(with the induced conformational changes of the ligand receptor complex how many of the receptor related genes are going to get transcriped, how kuch of the receptor is activated), this combined is potency of the agonist. with an antagonist it seems to me that the only important thing is binding affinity and complete imabikity of the complex to bind to a promotor element.It’s significantly more potent than RU - but we still have yet to see studies proving it’s effectiveness or anecdotes from people experimenting with it. Binding affinity isn’t the only thing that matters.
concentration is also important of course. if i recall correctly RU is delivered in a 5% concentration? is pyralutamide the same concentration?
i also wonder since many have reported sexual sides on RU why would this not happen on pyr if the affinity is higher and the concentration is the same?